Consensus ALS Limited

Equities

ALQ

AU000000ALQ6

Market Closed - Australian S.E. Other stock markets 02:10:04 2024-05-21 am EDT			5-day change	1st Jan Change
14.48 ^AUD	+5.00%		+8.87%	+12.68%

01:30am	Transcript : ALS Limited, 2024 Earnings Call, May 21, 2024
12:21am	ALS Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Evolution of the average Target Price on ALS Limited

Price target over the last 5 years

History of analyst recommendation changes

91a44d06df591401806.crMBwp1qNeNqBc8v2KfxrY7jyN381xopQgx9DOJJZJM.G4tk-uQjYbYfdrwfvIqUztaCvYXIoyxFdno0Z5R5LtdE5DCx3Ct-1C5rgg~8a8df8315a32d18a2fbc60400154d2a6

Analyst Recommendations on ALS Limited

Morgans Financial Downgrades ALS to Hold from Add, Price Target at AU$13.70	Apr. 01	MT
Jarden Adjusts ALS's Price Target to AU$13.70 from AU$13.80, Keeps at Buy	Mar. 25	MT
Jarden Adjusts ALS' Price Target to AU$13.80 From AU$13.40, Keeps at Buy	Mar. 21	MT
Australian Shares Rise as Investors Await US Inflation Data for Rate Hike Clues	Nov. 14	MT
UBS Adjusts ALS' Price Target to AU$13.15 From AU$13.10, Keeps at Neutral	22-08-25	MT
UBS Adjusts ALS' Price Target to AU$13.30 From AU$13.50, Keeps at Neutral	22-03-02	MT

More recommendations

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

OUTPERFORM

Number of Analysts

10

Last Close Price

13.79 AUD

Average target price

12.98 AUD

Spread / Average Target

-5.85%

High Price Target

15 AUD

Spread / Highest target

+8.77%

Low Price Target

8.9 AUD

Spread / Lowest Target

-35.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ALS Limited

Morgans Financial
Jarden Research
UBS

Ratings for ALS Limited

Trading Rating

Investor Rating

ESG Refinitiv

B+

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Stock Market
Equities
ALQ Stock
Consensus ALS Limited

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW